Literature DB >> 24299954

Active site proton delivery and the lyase activity of human CYP17A1.

Yogan Khatri1, Michael C Gregory1, Yelena V Grinkova1, Ilia G Denisov1, Stephen G Sligar2.   

Abstract

Cytochrome P450 CYP17A1 catalyzes a series of reactions that lie at the intersection of corticoid and androgen biosynthesis and thus occupies an essential role in steroid hormone metabolism. This multifunctional enzyme catalyzes the 17α-hydroxylation of Δ4- and Δ5-steroids progesterone and pregnenolone to form the corresponding 17α-hydroxy products through its hydroxylase activity, and a subsequent 17,20-carbon-carbon scission of pregnene-side chain produce the androgens androstenedione (AD) and dehydroepiandrosterone (DHEA). While the former hydroxylation reaction is believed to proceed through a conventional "Compound I" rebound mechanism, it has been suggested that the latter carbon cleavage is initiated by an iron-peroxy intermediate. We report on the role of Thr306 in CYP17 catalysis. Thr306 is a member of the conserved acid/alcohol pair thought to be essential for the efficient delivery of protons required for hydroperoxoanion heterolysis and formation of Compound I in the cytochromes P450. Wild type and T306A CYP17A1 self-assembled in Nanodiscs were used to quantitate turnover and coupling efficiencies of CYP17's physiological Δ4- and Δ5-substrates. We observed that T306A co-incorporated in Nanodiscs with its redox partner cytochrome P450 oxidoreductase, coupled NADPH only by 0.9% and 0.7% compared to the wild type (97% and 22%) during the conversion of pregnenolone and progesterone, respectively, to the corresponding 17-OH products. Despite increased oxidation of pyridine nucleotide, hydroxylase activity was drastically diminished in the T306A mutant, suggesting a high degree of uncoupling in which reducing equivalents and protons are funneled into non-productive pathways. This is similar to previous work with other P450 catalyzed hydroxylation. However, catalysis of carbon-carbon bond scission by the T306A mutant was largely unimpeded by disruption of the CYP17A1 acid-alcohol pair. The unique response of CYP17A1 lyase activity to mutation of Thr306 is consistent with a reactive intermediate formed independently of proton delivery in the active site, and supports involvement of a nucleophilic peroxo-anion rather than the traditional Compound I in catalysis.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  17α-hydroxy-pregnenolone; 17α-hydroxy-progesterone; AD; CYP17A1; Compound I; Cpd I; DHEA; Nucelophilic attack; OH-PREG; OH-PROG; PREG; PROG; Proton delivery; T306A; androstenedione; cyt-b(5); cytochrome b(5); dehydroepiandrosterone; pregnenolone; progesterone

Mesh:

Substances:

Year:  2013        PMID: 24299954      PMCID: PMC3912944          DOI: 10.1016/j.bbrc.2013.11.094

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  46 in total

1.  The role of cytochrome b5 in adrenal microsomal steroidogenesis.

Authors:  S Kominami; N Ogawa; R Morimune; H De-Ying; S Takemori
Journal:  J Steroid Biochem Mol Biol       Date:  1992-03       Impact factor: 4.292

2.  Expression of bovine 17 alpha-hydroxylase cytochrome P-450 cDNA in nonsteroidogenic (COS 1) cells.

Authors:  M X Zuber; E R Simpson; M R Waterman
Journal:  Science       Date:  1986-12-05       Impact factor: 47.728

3.  Biphasic response for hepatic microsomal enzyme induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice.

Authors:  E S Shen; F P Guengerich; J R Olson
Journal:  Biochem Pharmacol       Date:  1989-11-15       Impact factor: 5.858

4.  Expression and purification of functional human 17 alpha-hydroxylase/17,20-lyase (P450c17) in Escherichia coli. Use of this system for study of a novel form of combined 17 alpha-hydroxylase/17,20-lyase deficiency.

Authors:  T Imai; H Globerman; J M Gertner; N Kagawa; M R Waterman
Journal:  J Biol Chem       Date:  1993-09-15       Impact factor: 5.157

5.  Mechanism of the acyl-carbon cleavage and related reactions catalyzed by multifunctional P-450s: studies on cytochrome P-450(17)alpha.

Authors:  M Akhtar; D Corina; S Miller; A Z Shyadehi; J N Wright
Journal:  Biochemistry       Date:  1994-04-12       Impact factor: 3.162

6.  Adrenarche: a survey of rodents, domestic animals, and primates.

Authors:  G B Cutler; M Glenn; M Bush; G D Hodgen; C E Graham; D L Loriaux
Journal:  Endocrinology       Date:  1978-12       Impact factor: 4.736

7.  Role of Glu318 and Thr319 in the catalytic function of cytochrome P450d (P4501A2): effects of mutations on the methanol hydroxylation.

Authors:  K Hiroya; M Ishigooka; T Shimizu; M Hatano
Journal:  FASEB J       Date:  1992-01-06       Impact factor: 5.191

8.  Point mutations at threonine-301 modify substrate specificity of rabbit liver microsomal cytochromes P-450 (laurate (omega-1)-hydroxylase and testosterone 16 alpha-hydroxylase).

Authors:  Y Imai; M Nakamura
Journal:  Biochem Biophys Res Commun       Date:  1989-02-15       Impact factor: 3.575

9.  Cytochrome b5 promotes the synthesis of delta 16-C19 steroids by homogeneous cytochrome P-450 C21 side-chain cleavage from pig testis.

Authors:  S Nakajin; M Takahashi; M Shinoda; P F Hall
Journal:  Biochem Biophys Res Commun       Date:  1985-10-30       Impact factor: 3.575

10.  Crystal structure of the cytochrome P-450CAM active site mutant Thr252Ala.

Authors:  R Raag; S A Martinis; S G Sligar; T L Poulos
Journal:  Biochemistry       Date:  1991-12-03       Impact factor: 3.162

View more
  27 in total

1.  Cytochrome b5 enhances androgen synthesis by rapidly reducing the CYP17A1 oxy-complex in the lyase step.

Authors:  Ruchia Duggal; Ilia G Denisov; Stephen G Sligar
Journal:  FEBS Lett       Date:  2018-06-21       Impact factor: 4.124

2.  Correction to "Allosteric Interactions in Human Cytochrome P450 CYP3A4: The Role of Phenylalanine 213".

Authors:  Ilia G Denisov; Yelena V Grinkova; Prithviraj Nandigrami; Mrinal Shekhar; Emad Tajkhorshid; Stephen G Sligar
Journal:  Biochemistry       Date:  2019-06-06       Impact factor: 3.162

Review 3.  Nanodiscs in Membrane Biochemistry and Biophysics.

Authors:  Ilia G Denisov; Stephen G Sligar
Journal:  Chem Rev       Date:  2017-02-08       Impact factor: 60.622

Review 4.  Reconstituted Discoidal High-Density Lipoproteins: Bioinspired Nanodiscs with Many Unexpected Applications.

Authors:  Maki Tsujita; Anna Wolska; Daniel A P Gutmann; Alan T Remaley
Journal:  Curr Atheroscler Rep       Date:  2018-11-05       Impact factor: 5.113

5.  Active Site Structures of CYP11A1 in the Presence of Its Physiological Substrates and Alterations upon Binding of Adrenodoxin.

Authors:  Qianhong Zhu; Piotr J Mak; Robert C Tuckey; James R Kincaid
Journal:  Biochemistry       Date:  2017-10-20       Impact factor: 3.162

6.  Human cytochrome P450 17A1 conformational selection: modulation by ligand and cytochrome b5.

Authors:  D Fernando Estrada; Andria L Skinner; Jennifer S Laurence; Emily E Scott
Journal:  J Biol Chem       Date:  2014-03-26       Impact factor: 5.157

7.  Human P450 CYP17A1: Control of Substrate Preference by Asparagine 202.

Authors:  Michael C Gregory; Piotr J Mak; Yogan Khatri; James R Kincaid; Stephen G Sligar
Journal:  Biochemistry       Date:  2018-01-24       Impact factor: 3.162

8.  Human Cytochrome CYP17A1: The Structural Basis for Compromised Lyase Activity with 17-Hydroxyprogesterone.

Authors:  Piotr J Mak; Ruchia Duggal; Ilia G Denisov; Michael C Gregory; Stephen G Sligar; James R Kincaid
Journal:  J Am Chem Soc       Date:  2018-06-05       Impact factor: 15.419

Review 9.  Structural insights into the function of steroidogenic cytochrome P450 17A1.

Authors:  Rahul Yadav; Elyse M Petrunak; D Fernando Estrada; Emily E Scott
Journal:  Mol Cell Endocrinol       Date:  2016-08-24       Impact factor: 4.102

10.  Kinetic solvent isotope effect in steady-state turnover by CYP19A1 suggests involvement of Compound 1 for both hydroxylation and aromatization steps.

Authors:  Yogan Khatri; Abhinav Luthra; Ruchia Duggal; Stephen G Sligar
Journal:  FEBS Lett       Date:  2014-07-02       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.